Joincare Pharmaceutical Group Industry Co (SHSE:600380) 5-Year EBITDA Growth Rate : 12.40% (As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Joincare Pharmaceutical Group Industry Co 5-Year EBITDA Growth Rate?

Joincare Pharmaceutical Group Industry Co's EBITDA per Share for the three months ended in Mar. 2024 was ¥0.60.

During the past 12 months, Joincare Pharmaceutical Group Industry Co's average EBITDA Per Share Growth Rate was 2.00% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 10.70% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 12.40% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 12.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Joincare Pharmaceutical Group Industry Co was 80.90% per year. The lowest was -24.60% per year. And the median was 11.55% per year.

Competitive Comparison of Joincare Pharmaceutical Group Industry Co's 5-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Joincare Pharmaceutical Group Industry Co's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Joincare Pharmaceutical Group Industry Co's 5-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Joincare Pharmaceutical Group Industry Co's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Joincare Pharmaceutical Group Industry Co's 5-Year EBITDA Growth Rate falls into.

Joincare Pharmaceutical Group Industry Co 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Joincare Pharmaceutical Group Industry Co (SHSE:600380) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Joincare Pharmaceutical Group Industry Co 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Joincare Pharmaceutical Group Industry Co's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Joincare Pharmaceutical Group Industry Co (SHSE:600380) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Joincare Pharmaceutical Group Industry Co Ltd (SHSE:600380) » Definitions » 5-Year EBITDA Growth Rate

Traded in Other Exchanges

N/A

Address

No. 17 Langshan Road, Joincare Pharmaceutical Group Building, Nanshan New and High-Tech Industrial Development (, Shenzhen, Guangdong, CHN, 518057

Website

http://www.joincare.com

Joincare Pharmaceutical Group Industry Co Ltd is an integrated pharmaceutical company, the business scope covers healthcare products, APIs, final dosage forms, prescription drugs, OTCs, Chinese traditional medicine, chemical drugs, and testing agents. APIs are antibiotic series and their intermediates 7ACA, 4AA and F9. Prescription drugs focus on the realms of the digestive tract, a blood vessel of heart and brain, infection, tumor, nervous cerebrovascular section, urinary system etc. OTCs include gastrointestinal drug Dele-Livzon, Live Bifidobacterium Preparation, oral ulcer drugs Yiketie, cold medicine Antiviral Oral Granule, External use skin medicine.

Executives

Yu Xiong	Directors, senior managers
Zhao Feng Guang	senior management
Qiu Qing Feng	Directors, senior managers
Tang Ling Zhi	senior management
Lin Nan Qi	Directors, senior managers
Cao Ping Wei	Director
Feng Yan Fang	Director
Zhong Shan	senior management
Yang Dong Yun	senior management
Peng Jin Hua	Supervisors
Xie You Guo	Supervisors
Guo Xiao Yun	Supervisors
Su Qing Wen	senior management

Joincare Pharmaceutical Group Industry Co (SHSE:600380) Headlines

No Headlines